New Targeted Therapies in Myelodysplastic Syndrome: The Role of Farnesyltransferase and Proteasome Inhibitors
BMC Proceedings - United Kingdom
doi 10.1186/1753-6561-4-s2-p44
Full Text
Open PDFAbstract
Available in full text
Date
September 24, 2010
Authors
Publisher
Springer Science and Business Media LLC